+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Other Joint Reconstruction Market Outlook to 2025

  • PDF Icon

    Report

  • 125 Pages
  • July 2018
  • Region: United States
  • GlobalData
  • ID: 4586999
United States Other Joint Reconstruction Market Outlook to 2025

Summary

The author’s new report, United States Other Joint Reconstruction Market Outlook to 2025, provides key market data on the United States Other Joint Reconstruction market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Ankle Replacement, Digits Replacement, Elbow Replacement, Shoulder Replacement and Wrist Replacement.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Other Joint Reconstruction market categories - Ankle Replacement, Digits Replacement, Elbow Replacement, Shoulder Replacement and Wrist Replacement.

  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

  • 2017 company share and distribution share data for Other Joint Reconstruction market.

  • Global corporate-level profiles of key companies operating within the United States Other Joint Reconstruction market.

  • Key players covered include DePuy Synthes Inc, Stryker Corp, Zimmer Biomet Holdings Inc and Others.


Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.

  • Develop market-entry and market expansion strategies.

  • Design competition strategies by identifying who-stands-where in the market.

  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Other Joint Reconstruction Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Other Joint Reconstruction Market, United States
3.1 Other Joint Reconstruction Market, United States, Revenue ($m), 2015-2025
3.1.1 Ankle Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Digits Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Elbow Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.4 Shoulder Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.5 Wrist Replacement Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Other Joint Reconstruction Market, United States, Volume (Units), 2015-2025
3.2.1 Ankle Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Digits Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Elbow Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.2.4 Shoulder Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.2.5 Wrist Replacement Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Other Joint Reconstruction Market, United States, Average Price ($), 2015-2025
3.4 Other Joint Reconstruction Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Other Joint Reconstruction Market, United States, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United States, Other Joint Reconstruction Market
4.1 Wright Medical Group NV
4.1.1 Company Overview
4.2 DePuy Synthes Inc
4.2.1 Company Overview
4.3 Zimmer Biomet Holdings Inc
4.3.1 Company Overview
4.4 Stryker Corp
4.4.1 Company Overview
4.5 Exactech Inc
4.5.1 Company Overview
4.6 Integra LifeSciences Corp
4.6.1 Company Overview
5 Other Joint Reconstruction Market Pipeline Products
6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 Integra LifeSciences Prices Public Offering of Shares for USD307 Million
6.1.2 Amedica Files Registration Statement for Rights Offering of Units for up to USD11.4 Million
6.1.3 ConforMIS Prices USD20 Million in Public Offering of Shares
6.1.4 Histogenics Raises USD6.3 Million in Public Offering of Shares
6.1.5 OrthoPediatrics Raises USD59.8 Million in IPO
6.2 Partnerships
6.2.1 CellRight Technologies Enters into Distribution Agreement with Arthrex
6.3 Private Equity
6.3.1 JANA Partners Denies Rumor to Acquire Certain Stake in Zimmer Biomet
6.4 Venture Financing
6.4.1 Trilliant Surgical Raises USD5 Million in Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 May 14, 2018: OMNIlife science Appoints Rick Epstein as Chief Executive Officer
7.1.2 May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility
7.1.3 Apr 18, 2018: Histogenics Appoints Susan Washer As Board Director
7.1.4 Mar 19, 2018: Zimmer Biomet Appoints Coleman N. Lannum as Senior Vice President of Investor Relations
7.1.5 Mar 08, 2018: GSK announces positive EU approval for labelling update to Relvar Ellipta in patients with asthma
7.1.6 Mar 07, 2018: Medherant expands team with appointment of David Davies as Head of Development
7.1.7 Mar 03, 2018: Arthrex Announces New Vice President of Strategic Development
7.1.8 Jan 10, 2018: Spine Industry Veteran Paul Graveline Joins Spinal Elements
7.2 Financial Announcements
7.2.1 May 14, 2018: OrthoPediatrics Announces First Quarter 2018 Financial Results
7.2.2 May 10, 2018: Histogenics Announces First Quarter 2018 Financial and Operating Results
7.2.3 May 02, 2018: Conformis Reports First Quarter 2018 Financial Results
7.2.4 Apr 26, 2018: Zimmer Biomet Reports First Quarter 2018 Financial Results
7.2.5 Apr 26, 2018: Stryker reports first quarter 2018 operating results
7.2.6 Apr 11, 2018: Global Kinetics awarded grants from Michael J. Fox Foundation, Shake It Up Australia Foundation and Parkinson’s Victoria to advance management and outcomes in Parkinson’s disease
7.2.7 Apr 10, 2018: Asana BioSciences Announces Presentations of ASN007 (ERK1/2 inhibitor) at the American Association for Cancer Research Annual Meeting
7.2.8 Mar 15, 2018: Histogenics Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017
7.2.9 Mar 09, 2018: AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury
7.2.10 Mar 08, 2018: The Medicines Company Reaches Enrollment Target for ORION-10 Ahead of Schedule
7.2.11 Mar 07, 2018: OrthoPediatrics Reports Fourth Quarter and Full Year 2017 Financial Results
7.2.12 Mar 06, 2018: New Clinical Data Demonstrate High Vaccine Efficacy of Fluarix Tetra (Influenza Vaccine) in Children 6-35 Months of Age
7.2.13 Feb 27, 2018: Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results
7.2.14 Feb 07, 2018: ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance
7.2.15 Jan 30, 2018: Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results
7.2.16 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook
7.2.17 Jan 09, 2018: Stryker provides 2017 preliminary net sales results
7.2.18 Jan 08, 2018: Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Result
7.2.19 Jan 08, 2018: ConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial Guidance
7.2.20 Jan 05, 2018: OrthoPediatrics Announces Preliminary Revenue for Fourth Quarter and Full Year 2017
7.3 Government and Public Interest
7.3.1 Apr 09, 2018: OrthoPediatrics Announces Sponsorship of 2018 EPOS Meeting and Lunch Symposium
7.4 Legal And Regulatory
7.4.1 May 16, 2018: Zimmer Biomet Statement on Warsaw North Campus FDA Inspection
7.4.2 Dec 01, 2017: Amedica Receives Positive Nasdaq Listing Decision
7.4.3 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker
7.4.4 Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility
7.5 Other Significant Developments
7.5.1 May 08, 2018: Amedica Provides Update on its Clinical Studies
7.5.2 Apr 26, 2018: Episurf Medical enters into distribution agreement in Hong Kong and establishes subsidiary in the US
7.5.3 Oct 04, 2017: Zimmer Biomet Provides Update on Manufacturing Facilities in Guaynabo and Ponce, Puerto Rico
7.5.4 Sep 26, 2017: Integra LifeSciences Provides Preliminary Assessment of Minor Damage to its Manufacturing Facility in Anasco, Puerto Rico
7.6 Product News
7.6.1 Jan 18, 2018: Novel Method of Isolating Infecting Organisms after Joint Replacement
7.6.2 Oct 16, 2017: Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants
7.6.3 Sep 25, 2017: Bone Marrow Concentrate Improves Joint Transplants
7.7 Strategy And Business Planning
7.7.1 Nov 27, 2017: Spinal Elements Announces Headquarters and CEO Changes
7.7.2 Nov 09, 2017: Arthrex Announces Plans for Expansion of Global Headquarters
7.7.3 Oct 16, 2017: Arthrex Announces Plans for New Surgical Device Manufacturing Facility
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer
List of Tables
Table 1: Other Joint Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Other Joint Reconstruction Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Ankle Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Ankle Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Digits Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Digits Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Elbow Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Elbow Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Shoulder Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 10: Shoulder Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 11: Wrist Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 12: Wrist Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 13: Other Joint Reconstruction Market, United States, Volume (Units), 2015-2020
Table 14: Other Joint Reconstruction Market, United States, Volume (Units), 2021-2025
Table 15: Ankle Replacement Market, United States, Volume (Units), 2015-2020
Table 16: Ankle Replacement Market, United States, Volume (Units), 2021-2025
Table 17: Digits Replacement Market, United States, Volume (Units), 2015-2020
Table 18: Digits Replacement Market, United States, Volume (Units), 2021-2025
Table 19: Elbow Replacement Market, United States, Volume (Units), 2015-2020
Table 20: Elbow Replacement Market, United States, Volume (Units), 2021-2025
Table 21: Shoulder Replacement Market, United States, Volume (Units), 2015-2020
Table 22: Shoulder Replacement Market, United States, Volume (Units), 2021-2025
Table 23: Wrist Replacement Market, United States, Volume (Units), 2015-2020
Table 24: Wrist Replacement Market, United States, Volume (Units), 2021-2025
Table 25: Other Joint Reconstruction Market, United States, Average Price ($), 2015-2020
Table 26: Other Joint Reconstruction Market, United States, Average Price ($), 2021-2025
Table 27: Other Joint Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 28: Other Joint Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 29: Other Joint Reconstruction Market Pipeline Products
Table 30: Integra LifeSciences Prices Public Offering of Shares for USD307 Million
Table 31: Amedica Files Registration Statement for Rights Offering of Units for up to USD11.4 Million
Table 32: ConforMIS Prices USD20 Million in Public Offering of Shares
Table 33: Histogenics Raises USD6.3 Million in Public Offering of Shares
Table 34: OrthoPediatrics Raises USD59.8 Million in IPO
Table 35: CellRight Technologies Enters into Distribution Agreement with Arthrex
Table 36: JANA Partners Denies Rumor to Acquire Certain Stake in Zimmer Biomet
Table 37: Trilliant Surgical Raises USD5 Million in Venture Financing
Table 38: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Other Joint Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Ankle Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Digits Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Elbow Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Shoulder Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 6: Wrist Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 7: Other Joint Reconstruction Market, United States, Volume (Units), 2015-2025
Figure 8: Ankle Replacement Market, United States, Volume (Units), 2015-2025
Figure 9: Digits Replacement Market, United States, Volume (Units), 2015-2025
Figure 10: Elbow Replacement Market, United States, Volume (Units), 2015-2025
Figure 11: Shoulder Replacement Market, United States, Volume (Units), 2015-2025
Figure 12: Wrist Replacement Market, United States, Volume (Units), 2015-2025
Figure 13: Other Joint Reconstruction Market, United States, Company Share (%) 2017

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Wright Medical Group NV
  • DePuy Synthes Inc
  • Zimmer Biomet Holdings Inc
  • Stryker Corp
  • Exactech Inc
  • Integra LifeSciences Corp